1) TC21 alloy powder
TC21合金粉末
1.
To obtain compaction property evaluation system and establish quantitative relationship between green density and every processing parameters at room temperature die forming of hydrogenated TC21 powder,it was tested that the relationship between forming pressure,green density,compression strength and hydrogen content of hydrogenated TC21 alloy powder.
为建立置氢TC21钛合金粉末的压制性能评价体系,和置氢TC21合金粉末室温模压成形过程压制方程,测定了置氢TC21合金粉末外加压力、压坯密度及压坯强度与合金粉末置氢量的关系,将试验数据代入推导的置氢TC21钛合金粉末的压制方程之中,采用VB求解超限定方程组,计算出方程中所含的3个参数的值,并最终定量研究了这3个参数与置氢量的关系,确定了占主导地位的成形机制,最终得到了置氢TC21合金粉末压制性能及压制方程,从而为精确控制置氢钛合金粉末模压成形提供了依据。
3) TC21 titanium alloy
TC21钛合金
1.
Electron beam welding of TC21 titanium alloy with large thickness
大厚度TC21钛合金电子束焊接试验
2.
Research on blocky alpha in beta processed TC21 titanium alloy
TC21钛合金β锻造大块α相研究
3.
Influence of pulsed electron beam polishing modification on surface morphologies of TC21 titanium alloy
脉冲电子束抛光改性处理对TC21钛合金表面形貌的影响
4) TC21 alloy
TC21合金
1.
Constitutive relationship model of TC21 alloy during superplastic deformation based on BP artificial neural network
TC21合金超塑性本构关系的BP人工神经网络模型
2.
Strain and Stress Controlled Low Cycle Fatigue Behaviors of TC21 alloy
TC21合金应力控制和应变控制的低周疲劳行为
3.
The effect of notch on the high cycle and low cycle fatigue strength of TC21 alloy at different temperatures has been investigated in this paper.
研究了缺口对TC21合金在不同温度高周和低周疲劳强度的影响。
5) TC21
TC21合金
1.
Effect of Heat Treatment on Microstructure and Tensile Properties of TC21 Alloy;
热处理对TC21合金显微组织和室温拉伸性能的影响
2.
TC21 alloy is a new kind of high strengthand high toughness titanium alloy.
结果表明,在Tβ(-20-50℃)/1 h AC+600℃/4 h AC处理制度下,TC21合金Φ20 mm棒材的室温拉伸强度和塑性分别为:抗拉强度≥1105 MPa,屈服强度(1000MPa,延伸率≥15%,断面收缩率≥43%。
6) TC21 alloy
钛合金TC21
1.
The behavior of hydrogen absorption on microstructure of TC21 alloy as cast was studied.
本文研究了α+β型钛合金TC21铸态组织的高温渗氢行为,通过对合金渗氢前、后和除氢后的显微组织观察发现,渗氢后β相的数量明显增加,并有氢化物的生成;除氢后,晶粒组织得到细化,原始晶界变得模糊,其相应的硬度也发生了一定变化。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条